MALT lymphoma (maltoma)
MALT lymphoma (mucous associated lymphoma tissue) or maltoma – a form of non-Hodgkin’s lymphoma that occurs in about 8%, it is also a third type of lymphoma the most common of all NHL. These forms of lymphoma grow slowly and usually persist for a long time at the site of its origination.
Leading experts on the treatment of diseases of the circulatory and lymphatic systems in Israel are:
Professor Gideon Rechavi – a specialist in the treatment of children’s oncology, brain tumors and leukemia, Director of the Research Cancer Center, Sheba Medical Center, Tel Hashomer
Professor Isaac Yaniv – expert in pediatric oncology and bone marrow transplantation, Director of Hematology Schneider Children’s Hospital
Multi-cell lymphoma develops in lymphatic tissue, mucosal tissues or organs surrounding the abdominal cavity, including organs of the gastrointestinal tract (typically the stomach, but can also occur in the intestine and colon), in the eye tissues, skin, salivary glands, thyroid and breast.
The disease can occur at any age, but usually affects people aged 60 years. Lymphoma is more common in women than in men.
Many people with lymphoma of the stomach infected with Helicobacter Pylori. Bacterial or viral infection are also associated with other forms of lymphoma. Also people who have discovered maltoma often have a history of autoimmune diseases such as Hashimoto’s thyroiditis (thyroid lymphoma), and Sjogren’s syndrome (lymphoma sweat, lacrimal and salivary glands).
Treatment is assigned an experienced diagnostic results and given the stage of the disease and the general condition of the patient.
Most forms of lymphoma develops slowly, localized in one place and respond well to treatment. At the beginning of the treatment, if maltoma stomach is usually assigned local treatment – radiotherapy or surgery. In more advanced stages of MALT lymphoma (stage 3 or 4) is generally assigned systemic treatment – chemotherapy.
Patients with stomach maltoma that were infected with H. Pylori can achieve long periods of remission generally after effective antibiotic treatment. These drugs affect the reduction of lymphoma.
For patients with gastric lymphoma which does not develop the doctor can apply “wait and see” approach.